Average Co-Inventor Count = 8.55
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Scripps Research Institute (13 from 1,187 patents)
2. International Aids Vaccine Initiative (13 from 68 patents)
3. Theraclone Sciences, Inc. (13 from 28 patents)
4. Cornell University (6 from 1,361 patents)
5. Memorial Sloan Kettering Cancer Center (2 from 559 patents)
6. Theraclone Science, Int. (0 patent)
19 patents:
1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
2. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
3. 12122844 - Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
4. 12031144 - Oxidation-resistant AAT gene therapy
5. 12024568 - Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
6. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
7. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
8. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
9. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
10. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
11. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
12. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
13. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
14. 10093947 - AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
15. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody